6015 Bordetella Supplement, Condalab

Isolation of Bordetella species from nasopharyngeal swabs is often challenging due to their slow growth rate and the presence of rapidly growing upper respiratory tract flora. This supplement contains Cephalexin, a first-generation cephalosporin. Cephalexin is highly effective at suppressing most Gram-positive and Gram-negative bacteria found in the nasopharynx, such as Staphylococcus species and various coliforms, while Bordetella species remain relatively resistant. By incorporating this selective agent, the overgrowth of background microflora is prevented, which is critical during the 3 to 7-day incubation period required for Bordetella.

Advantages

• High Selectivity: Specifically targeted to suppress the competing microflora of the human respiratory tract.
• Improved Recovery: Increases the diagnostic yield from clinical specimens by preventing the overgrowth of non-target organisms.
• Stability: Formulated as a freeze-dried (lyophilized) powder to ensure the long-term stability and potency of the antibiotic.
• Standardized Concentration: Each vial is precisely dosed for a specific volume of medium (500 mL), ensuring consistent selective pressure across batches.
• Essential for Clinical Diagnosis: A critical component in the gold-standard culture methods for pertussis monitoring and diagnosis.

Technical specifications

Available packaging options